Clinical Research Unit, Khoo Teck Puat Hospital, Singapore.
Clinical Research Unit, Khoo Teck Puat Hospital, Singapore; Diabetes Centre, Admiralty Medical Centre, Khoo Teck Puat Hospital, Singapore.
Diabetes Res Clin Pract. 2023 May;199:110634. doi: 10.1016/j.diabres.2023.110634. Epub 2023 Mar 21.
We explored the predictive utility of baseline neutrophil/lymphocyte ratio (NLR), which reflects a systemic inflammatory tone, in kidney impairment in type 2 diabetes mellitus (T2DM); and investigated the effect of extracellular water/total body water (ECW/TBW) ratio on the relationship.
This longitudinal study included 1,224 T2DM adults recruited from a single centre. Cox regression analyses examined the association between NLR and progressive kidney function decline or albuminuria progression. Improvements in risk discrimination were assessed using Harrell's concordance-statistics. The mediatory role of ECW/TBW ratio estimated by bioelectrical impedance was evaluated.
Higher baseline NLR levels were observed in cases with kidney function decline or albuminuria progression over a median 2-year follow-up. NLR independently predicted progressive kidney function decline (hazard ratio:1.39, 95% CI:1.21-1.60, P < 0.001) or albuminuria progression (hazard ratio:1.34, 95% CI:1.08-1.68, P = 0.009). Addition of NLR to a base model comprising demographics, T2DM duration, metabolic and renal parameters, and medications significantly improved the risk discrimination of kidney function decline (P = 0.022) but not albuminuria progression. ECW/TBW ratio accounted for 19.7% of the total effect between NLR and kidney function loss.
Increased NLR reflecting systemic inflammation is associated with progressive kidney function decline in T2DM, partially explained by dysregulated body fluid balance.
本研究旨在探讨基线中性粒细胞/淋巴细胞比值(NLR)的预测价值,该比值反映了全身炎症状态,在 2 型糖尿病(T2DM)患者的肾功能损害中;并研究细胞外液/总体水(ECW/TBW)比值对这种关系的影响。
这项纵向研究纳入了 1224 名来自单一中心的 T2DM 成年患者。Cox 回归分析评估了 NLR 与肾功能进行性下降或蛋白尿进展之间的关系。采用 Harrell 一致性统计评估风险判别能力的改善。通过生物电阻抗法评估细胞外液/总体水比值对 NLR 与肾功能下降关系的中介作用。
在中位 2 年的随访中,观察到基线 NLR 水平较高的患者更易发生肾功能下降或蛋白尿进展。NLR 独立预测肾功能进行性下降(危险比:1.39,95%可信区间:1.21-1.60,P<0.001)或蛋白尿进展(危险比:1.34,95%可信区间:1.08-1.68,P=0.009)。在包含人口统计学、T2DM 病程、代谢和肾脏参数以及药物治疗的基本模型中加入 NLR,显著改善了肾功能下降的风险判别能力(P=0.022),但对蛋白尿进展无影响。ECW/TBW 比值解释了 NLR 与肾功能丧失之间总效应的 19.7%。
反映全身炎症的 NLR 升高与 T2DM 患者的肾功能进行性下降有关,部分原因是体液平衡失调。